Explore every episode of the podcast Data Science x Public Health

Resource allocation models are supposed to help public health systems distribute scarce resources more intelligently.
They promise better targeting, more efficient deployment, and stronger impact under constraint.

But what if the model is optimizing inside a system whose deepest constraints should never have been treated as fixed?

In this episode, we break down why resource allocation models often fail in practice, how optimization can normalize structural scarcity, and why better public health modeling has to question the system—not just distribute within it.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Censoring is one of the most common assumptions in epidemiology and survival analysis. It is often treated as a routine technical step for handling people who leave observation before the study ends. But what if leaving the study is not random noise—and is actually part of the outcome process itself? 

In this episode, we break down why censoring assumptions often fail, how loss to follow-up can distort longitudinal research, and why disappearing from the dataset is not the same thing as disappearing from risk.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Model averaging is often presented as a more careful and uncertainty-aware alternative to choosing one model specification. It is supposed to reduce overconfidence and make analysis more robust. But what if all the models being averaged share the same blind spots from the start? 

In this episode, we break down why model averaging often overpromises, how shared structural weaknesses survive the averaging process, and why uncertainty cannot be handled simply by blending similar models. 

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at: 

📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Real-time health alerts are supposed to detect danger faster and trigger earlier intervention.
They promise speed, precision, and smarter public health response.

But what if the alert is fast and the system behind it is still slow?

In this episode, we break down why real-time health alerts often fail in practice, how organizational bottlenecks override detection speed, and why early warning only matters when the response pathway is built to act.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

External validation is often presented as the gold standard for proving that a predictive model works beyond its original dataset. It is supposed to show that the model can generalize to the real world. But what if one external dataset is still far too small a test of the outside world? 

In this episode, we break down why external validation often overpromises, how “different” datasets can still be too similar, and why transportability is a much harder claim than validation language suggests.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at: 📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Competing risks methods are often presented as a more realistic way to analyze time-to-event data in epidemiology and public health. They promise to handle situations where other events prevent the outcome of interest from ever occurring. But what if the method becomes more sophisticated while the interpretation becomes less clear? 

In this episode, we break down why competing risks analyses are often overtrusted, how the choice of estimand quietly changes what the result means, and why better methods do not remove the need for sharper scientific thinking.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at: 📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Attack rates are one of the most common tools in outbreak epidemiology. They seem to offer a quick answer to a simple question: how many exposed people got sick? But what if the exposed group was never truly sharing the same exposure in the first place? 

In this episode, we break down why attack rates often fail when exposure is uneven, how denominator assumptions distort outbreak interpretation, and why summary measures can hide the real structure of transmission.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Public health scorecards are supposed to improve accountability and make system performance easier to track.
They promise clarity, targets, and faster decision-making.

But what if the scorecard starts changing behavior in the wrong direction?

In this episode, we break down why public health scorecards often fail, how metrics become incentives, and why better-looking numbers can still hide weaker real-world performance.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Adjustment for baseline differences is one of the most common moves in health research and biostatistics. It is often treated as proof that two groups have been made more comparable and that bias has been reduced. But what if that adjustment is creating more confidence than the data actually deserve? 

In this episode, we break down why baseline adjustment often fails, how observed balance can hide deeper structural non-comparability, and why adjusting for differences is not the same as solving them.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

AI triage tools are designed to identify high-risk patients and communities faster.
They promise smarter prioritization, earlier intervention, and more efficient care delivery.

But what if the model is not the real bottleneck at all?

In this episode, we break down why AI triage tools often fail in real-world public health settings, how system constraints can cancel out model performance, and why prediction only matters when the response system can actually act.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Secondary attack rates are often used to estimate how infection spreads among close contacts. They seem to provide a focused measure of transmission in households, schools, workplaces, and other settings. But what if the number is being shaped just as much by contact tracing and testing rules as by the pathogen itself? 

In this episode, we break down why secondary attack rates often mislead, how inconsistent contact definitions distort interpretation, and why outbreak metrics cannot be separated from investigation design.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Sensitivity analyses are often presented as proof that a result is robust and trustworthy. They are supposed to show that findings hold up even when assumptions are changed. But what if the analysis only tested a tiny corner of the uncertainty that actually matters? 

In this episode, we break down why sensitivity analyses often fail, how local robustness can create false reassurance, and why truly strong evidence has to challenge deeper sources of fragility.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Statistical power is one of the most familiar concepts in biostatistics and research design. It is supposed to help determine whether a study can detect a meaningful effect. But what if power is being used the wrong way after the study is already finished? 

In this episode, we break down what statistical power actually means, why post hoc power language often misleads, and why large or “well-powered” studies are not automatically strong evidence.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Health equity dashboards are supposed to make disparities visible and drive better public health decisions.
They promise transparency, accountability, and measurable progress.

But what if the dashboard is making inequity easier to display without making it easier to solve?

In this episode, we break down why health equity dashboards often fail, how they can turn structural inequality into performance theater, and why visibility is not the same as meaningful institutional change.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Prevalence is one of the most commonly used measures in epidemiology. It is often treated as a direct indicator of disease risk, spread, or public health urgency. But what if prevalence is telling a very different story than most people think? 

In this episode, we break down what prevalence actually measures, why it is often confused with incidence and risk, and how that misunderstanding can distort public health interpretation and policy decisions.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

We’re making a small but important update to the podcast schedule.

To focus on delivering higher-quality, more in-depth content, we’re moving to a new release format: Triple-Drop Wednesdays.

Starting next week, all three weekly episodes—covering data science in public health, epidemiology, and biostatistics—will be released together every Wednesday.

This change allows for deeper insights while also giving you more time to catch up on past episodes and get the most value from the content.

Appreciate you all for listening and supporting the podcast.

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Statistical significance is one of the most familiar ideas in research. It is often treated as the dividing line between real evidence and random noise. But what if that binary framing is doing more harm than good?

In this episode, we break down why statistical significance often misleads, how threshold thinking distorts interpretation, and why effect size, uncertainty, and design quality matter far more than a simple significant versus non-significant label.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Outbreak curves are one of the most recognizable tools in epidemiology. They appear to show whether an epidemic is rising, peaking, or falling in real time. But what if the curve is reflecting reporting behavior as much as disease transmission? 

In this episode, we break down why outbreak curves often mislead, how reporting delays and revisions distort the shape people think they are seeing, and why epidemiologic interpretation has to go deeper than the visual alone.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Predictive models are widely used to identify high-risk patients and populations.
They promise earlier intervention, better resource allocation, and improved outcomes.

But what if prediction alone is not enough to actually change what happens next?

In this episode, we break down the critical difference between prediction and causation—and why models that perform well statistically can still fail when used in real-world decision-making. You will learn why predicting risk is not the same as knowing what action to take, and how this gap affects healthcare and public health systems.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Case fatality rate is one of the most commonly cited numbers during outbreaks and health emergencies. It seems to offer a direct answer to a simple question: how deadly is this disease? But what if the rate is being shaped less by biology and more by who gets detected as a case? 

In this episode, we break down why case fatality rates often fail when detection is unequal, how testing and surveillance distort the denominator, and why context matters when interpreting outbreak severity.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at: 📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Subgroup analysis is one of the most persuasive tools in biostatistics and clinical research. It promises to show who benefits most, who responds differently, and where average effects break apart. But what if the study was never designed to answer those subgroup questions reliably? 

In this episode, we break down why subgroup analysis so often misleads, how multiple testing and unstable estimates create false confidence, and why the most personalized-looking result may be the weakest result in the paper.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Health risk maps are one of the most persuasive tools in public health.
They make danger visible, focus attention, and seem to show exactly where action is needed most.

But what if the map is already out of date by the time anyone uses it?

In this episode, we break down why health risk maps often fail when the data is delayed, how visual precision hides temporal weakness, and why public health decisions can go wrong when systems treat stale data like live intelligence.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Incidence rates are one of the most common measures in epidemiology. They are used to describe how quickly disease is appearing in a population and to compare risk across groups. But what if the rate looks correct while the underlying time at risk is completely wrong? 

In this episode, we break down why incidence rates fail when person-time is misdefined, how denominator errors distort epidemiologic findings, and why this problem matters for surveillance, cohort studies, and public health decision-making. 

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Standard errors are one of the most overlooked pieces of statistical output. They sit underneath confidence intervals, p-values, and claims about precision in almost every study. But what if those standard errors are wrong from the start? 

In this episode, we break down what standard errors actually represent, why they often fail when real-world data violate model assumptions, and how this creates false confidence in research findings.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Benchmark accuracy is one of the most trusted signals in machine learning. It tells you which model performs best—and it often drives decisions about what gets deployed. But what if that number is giving you a false sense of confidence? 

In this episode, we break down why models that perform well on benchmarks often fail in real-world settings. You will learn how dataset assumptions, evaluation metrics, and deployment conditions create a gap between leaderboard success and practical reliability. 

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Screening programs are often seen as one of the clearest wins in public health. Find disease earlier, intervene sooner, and improve outcomes. But what if some screening programs only appear effective because of bias, overdiagnosis, and misleading outcome measures?

In this episode, we break down why screening can fail, how lead-time bias and overdiagnosis distort interpretation, and why finding disease earlier is not the same as improving population health. If you care about prevention, public health policy, or epidemiologic evidence, this is a critical topic to understand.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Confidence intervals are everywhere in research. They are supposed to show uncertainty, improve interpretation, and give more context than a single point estimate. But what if confidence intervals are creating a false sense of certainty instead? 

In this episode, we break down what confidence intervals actually mean, why narrow intervals can still be misleading, and how people in research, medicine, and public health often confuse precision with truth. If you read scientific papers or work with data, this is a concept you need to understand.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Cross-validation is one of the most common tools in machine learning.
It is supposed to give you a reliable estimate of how your model will perform.

But what if that estimate is quietly misleading you?

In this episode, we break down why cross-validation often fails in real-world healthcare and public health data. From data leakage and time dependence to population shifts and deployment mismatch, you will learn why validation strategies that look rigorous can still produce fragile models.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Regression adjustment is one of the most common tools in biostatistics and health research. It is often treated as proof that a study has properly controlled for differences and moved closer to the truth. But what if regression adjustment is creating more confidence than validity? 

In this episode, we break down why regression models often fail to remove bias, how adding more covariates can sometimes make analysis worse, and why statistical control is much weaker than most people think. If you use or interpret regression results, this is a concept you cannot afford to ignore.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Confounding adjustment is one of the most common phrases in epidemiology and observational research. It is often treated as proof that a study has handled bias and moved closer to a causal answer. But what if adjustment is creating more confidence than the data actually deserve? 

In this episode, we break down why confounding adjustment often fails, how poorly measured or incorrectly chosen variables leave bias behind, and why “adjusted” is not the same thing as “causal.” If you read or produce observational research, this is an essential concept to understand.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Risk scores are used everywhere in healthcare and public health.
They are designed to identify who is most at risk and where interventions should be targeted.

But what if those scores are quietly reflecting unequal systems of care rather than true need?

In this episode, we break down how bias enters risk models through utilization, access, and data structure—and why even high-performing models can fail the populations that need help most. You will learn why fairness cannot be solved by metrics alone and what better model design and evaluation actually look like.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

P-values are everywhere in research. They are treated as the standard for determining whether a result is real, meaningful, or worth acting on. But what if statistical significance is answering the wrong question? 

In this episode, we break down why p-values often fail when the real goal is causal inference. You will learn what a p-value actually measures, why it cannot establish causality, and how study design, confounding, and bias matter far more than a single threshold like 0.05. 

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Infectious disease models shape some of the biggest public health decisions in the world—from vaccine strategy to lockdown timing to hospital surge planning. 

But what do these models actually do? How do SIR models work? Why do forecasts change? And why do so many people misunderstand what a model is supposed to tell us?

In this episode, we break down infectious disease modeling in plain English: the core compartments, the meaning of R0, how calibration works, why assumptions matter, and what these models can—and cannot—predict.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Dashboards are supposed to make decision-making easier.
They make data visible, trends accessible, and performance look measurable in real time.

But what if that visibility is giving leaders the wrong kind of confidence?

In this episode, we break down why dashboards often fail to improve real decision-making—especially in public health and data science. From missing context and misleading metrics to surveillance lag and what I call metric theater, this episode explains why seeing more data is not the same as understanding more.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Every 7 seconds, a preventable maternal death occurs worldwide.
And in the United States, the numbers are getting worse—not better.

So what’s really going on?

In this episode, we break down maternal and perinatal epidemiology—the field that reveals the true state of a nation’s health system. From rising maternal mortality rates to racial disparities and healthcare access gaps, the data tells a story most people never see.

If you want to understand where healthcare systems succeed—or fail—look at pregnancy outcomes.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

AI can now write like an experienced epidemiologist.
Clear. Structured. Confident.
But what happens when it’s wrong?

In this episode, we break down how large language models (LLMs) are being used in public health — from surveillance summaries to clinical decision support — and why their biggest strength is also their biggest risk.

You’ll learn:
What LLMs actually are (and what they’re not)
Where they’re already used in public health
Why hallucinations happen — and why they’re dangerous
The guardrails (RAG, validation, governance) that make them usable
The future of public health will use AI.
The real question is whether it can be trusted.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

What if one of the most common methods in medical research is quietly giving you the wrong answer?

In studies where patients can experience more than one outcome, standard survival analysis methods like Kaplan-Meier can overestimate risk—sometimes by a lot.

In this episode, we break down competing risks analysis, why traditional approaches fail, and how methods like cause-specific hazards and the Fine-Gray model give you the correct answer.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Everyone talks about neural networks.
But the systems quietly running public health? They don’t learn — they follow rules.
In this episode, we break down symbolic AI — the rule-based systems behind clinical decision support, disease surveillance, and health regulations.

You’ll learn:
What symbolic AI actually is
Where it’s already used in healthcare and public health
Why neural networks fall short in high-stakes systems
Why the future is hybrid (neuro-symbolic AI)
This is the side of AI most people overlook — but it’s the one systems trust.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Healthcare is producing more data than ever before — electronic health records, wearables, genomic data, insurance claims, and real-time patient monitoring.

But data alone doesn’t solve problems.

In this episode, we break down health data science — the field where biostatistics, machine learning, and modern healthcare systems come together. You’ll learn what health data science actually is, how it differs from traditional biostatistics, and why it’s one of the fastest-growing careers in public health and data science.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

We’ve known the major causes of heart disease for decades.

Smoking. Cholesterol. Blood pressure. Diabetes.

So why is it still the leading cause of death worldwide?

In this episode, we break down cardiovascular epidemiology — from the Framingham Heart Study to modern advances in genetics, wearables, and AI.

You’ll learn:

• How risk factors were discovered
• Why “residual risk” still exists
• How genetics and polygenic risk scores are changing the field
• The role of policy, prevention, and health disparities

This isn’t just history — it’s where the future of public health is being built.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

AI models in healthcare are making critical decisions every day…
Who gets flagged as high-risk.
Where resources are sent.
Who gets care first.

But there’s a problem:
Many of these models can’t explain their decisions.
In this episode, we break down Explainable AI (XAI) and why black-box models are a serious risk in public health. You’ll learn how tools like SHAP and LIME reveal what’s really happening inside AI — and why transparency is becoming non-negotiable.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Cancer cases are still rising…

But cancer deaths have dropped 34% since 1991 — preventing millions of deaths.

So what changed?

In this episode, we break down cancer epidemiology — the hidden system of data, registries, and research that reveals who gets cancer, why it happens, and how we prevent it at scale.

From risk factors like smoking to screening programs and health disparities, this is the science quietly shaping the fight against cancer.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

What if you could run a clinical trial… without randomizing anyone?

In this episode, we break down propensity score methods — one of the most important tools in biostatistics for turning messy observational data into something closer to a fair comparison.

You’ll learn:

• Why observational studies are biased by default
• How propensity scores balance treated vs untreated groups
• The 4 major methods (matching, weighting, stratification, adjustment)
• When they work… and when they fail

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

AI models trained in top hospitals often fail when deployed elsewhere. Different populations. Different data. Different outcomes.

So how do you make AI work in places with limited data?

In this episode, we break down transfer learning — the technique that lets models reuse what they’ve already learned and adapt to new environments. From rural clinics to global health systems, this method is helping close the gap between data-rich and data-limited settings.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Before any study begins, one question determines everything:

How many participants do you need?

Get it wrong, and your study can miss real effects… or waste time, money, and lives.

In this episode, we break down sample size and power analysis — the foundation of every clinical trial and research study. You’ll learn how effect size, power, variability, and significance level all come together to determine the one number that decides whether your study succeeds or fails.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Every year, millions of people die from injuries — and most of us call them “accidents.”

But what if that’s completely wrong?

In this episode, we break down injury epidemiology — the science of understanding and preventing harm before it happens. From car crashes to falls to workplace injuries, these events follow patterns, risk factors, and can be systematically reduced.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Why can two neighborhoods in the same city have a 15-year difference in life expectancy?

This episode explains social epidemiology—the field that studies how income, education, housing, and social structures shape health outcomes. We break down key frameworks, real-world examples, and why understanding social determinants of health is essential for modern public health practice.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review—it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Most AI models in public health focus on prediction. Reinforcement learning takes it a step further—it learns what actions to take and improves over time through feedback.

In this episode, we break down how reinforcement learning works, why it is a natural fit for public health decision-making, and how it is being applied to outbreak response, resource allocation, and personalized treatment strategies.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Functional MRI (fMRI) lets scientists see your brain in action. This beginner-friendly episode breaks down the core concepts—BOLD contrast, hemodynamic response, task-based vs. resting-state fMRI—and walks through the statistical analysis pipeline. Learn the challenges researchers face and why fMRI is so valuable in biostatistics and neuroscience.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting

Clinical trials traditionally rely only on data from newly enrolled patients. But Bayesian borrowing allows researchers to incorporate external data from past studies to strengthen new trials.

In January 2026, the FDA released draft guidance expanding how sponsors can use external controls and Bayesian methods in clinical trials. This episode explains how Bayesian borrowing works, why it can make trials faster and smaller, and the risks regulators are trying to control.

👉 Enjoyed the episode? Follow the show to get new episodes automatically.

If you found the content helpful, consider leaving a rating or review — it helps support the podcast.

For business and sponsorship inquiries, email us at:
📧 contact@bjanalytics.com

Youtube: https://www.youtube.com/@BJANALYTICS

Instagram: https://www.instagram.com/bjanalyticsconsulting/

Twitter/X: https://x.com/BJANALYTICS

Threads: https://www.threads.com/@bjanalyticsconsulting